IP Portfolio Update

14 Mar 2017

Patent estate fortified for Feraccru® building internationally on the 2034 UK exclusive position. To read the full report please see the link below.

Shield Therapeutics Press Release IP March 2017

Back to news

London, UK

One Euston Square
40 Melton Street
London, NW1 2FD

t+44 (0) 207 186 8500

einfo@shieldtx.com

Newcastle, UK

Northern Design Centre
Baltic Business Quarter
Gateshead Quays, NE8 3DF

t+44 (0) 191 511 8500

einfo@shieldtx.com

Wollerau, Switzerland

Shield Therapeutics
c/o Shield Holdings AG
Sihleggstrasse 23, 8832 Wollerau

t+41 (0) 435 080 781

einfo@shieldtx.com

Munich, Germany

Shield Therapeutics (DE)
Leopoldstr. 23
80802 München, Germany

einfo@shieldtx.com